Renaissance Technologies
PTPI

Renaissance Technologies’s Petros Pharmaceuticals PTPI Stock Holding History

Renaissance Technologies’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-671
Closed -$34K – 4010
2023
Q2 		$34K Buy
+671
New +$52.3K ﹤0.01% 3683
2021
Q4 		– Sell
-217
Closed -$109K – 4162
2021
Q3 		$109K Sell
217
-3
-1% -$1.95K ﹤0.01% 3308
2021
Q2 		$172K Sell
220
-522
-70% -$417K ﹤0.01% 3276
2021
Q1 		$692K Buy
742
+169
+29% +$159K ﹤0.01% 2777
2020
Q4 		$630K Buy
+573
New +$539K ﹤0.01% 2720

Other funds holding PTPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's PTPI Position: Q3 2023 in Review

Renaissance Technologies sold out of Petros Pharmaceuticals (PTPI) in Q3 2023, closing a stake of 671 shares — an estimated $34K sold.

Renaissance Technologies first reported a position in PTPI in Q4 2020 and held it in 5 quarters. The position peaked at $692K in Q1 2021. 11 funds tracked by Wall St. Rank hold PTPI as of Q3 2023.

  • Renaissance Technologies reported no remaining Petros Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 671 Petros Pharmaceuticals shares in Q3 2023, an estimated $34K.
  • Renaissance Technologies first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 5 quarters.
  • Renaissance Technologies's Petros Pharmaceuticals position peaked at $692K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.